Prescription rates increased from 2021 to 2023, but high variance seen between hospitals in the rate of prescriptions
President-Elect Trump Names His Picks to Head the CDC and FDA
In addition, the president-elect has chosen his nominee for surgeon general
AHA: Bumetanide Nasal Spray Statistically Bioequivalent to Oral Bumetanide
Nasal spray absorbed more rapidly than oral tablet and has comparable pharmacodynamic effects of diuresis and natriuresis
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk
Reduction in levels seen using an intact lipoprotein(a) assay and apolipoprotein(a)-based assay
Heart Failure With Preserved Ejection Fraction Underdiagnosed
Findings seen in patients with severe secondary tricuspid regurgitation of undefined etiology
Considerable Disparities in Life Expectancy Exist Within U.S. Population
Large disparities in life expectancy observed, which grew over time, especially during the first two years of COVID-19
AHA: Tirzepatide Beneficial for Heart Failure With Preserved EF, Obesity
Lower risk for composite of death from cardiovascular causes or worsening heart failure seen with tirzepatide versus placebo
AHA: Half of U.S. Adults Are Eligible for Treatment With Semaglutide
More than 39 million U.S. adults qualify for indications other than weight management alone
AHA: Initial Catheter Ablation Beneficial for Ventricular Tachycardia
Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy
U.S. Overweight, Obesity Rates Set to Continue Increasing to 2050
Total number of children and adolescents with overweight and obesity expected to reach 43.1 million by 2050